Jump to content

α-Ethylmescaline

From Wikipedia, the free encyclopedia
AEM
Names
Preferred IUPAC name
1-(3,4,5-Trimethoxyphenyl)butan-2-amine
Other names
3,4,5-Trimethoxy-α-ethylphenethylamine
α-ethyl-3,4,5-trimethoxyphenethylamine
α-Ethyl-3,4,5-trimethoxybenzeneethanamine
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C13H21NO3/c1-5-10(14)6-9-7-11(15-2)13(17-4)12(8-9)16-3/h7-8,10H,5-6,14H2,1-4H3 checkY
    Key: DCYONQVUAUEKAJ-UHFFFAOYSA-N checkY
  • InChI=1/C13H21NO3/c1-5-10(14)6-9-7-11(15-2)13(17-4)12(8-9)16-3/h7-8,10H,5-6,14H2,1-4H3
    Key: DCYONQVUAUEKAJ-UHFFFAOYAD
  • COc1c(cc(cc1OC)CC(N)CC)OC
  • O(c1cc(cc(OC)c1OC)CC(N)CC)C
Properties
C13H21NO3
Molar mass 239.31 g/mol
Legal status
  • AU: S9 (Prohibited substance)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)

α-Ethylmescaline (AEM or 3,4,5-trimethoxy-α-ethylphenethylamine) is a lesser-known psychedelic drug. It is an analog of mescaline. AEM was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 220 mg, and the duration unknown.[1] AEM produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of AEM.

See also

[edit]
[edit]

References

[edit]